Camber Pharma Launches Generic Baraclude®
Piscataway, NJ, August 21, 2015– Camber Pharmaceuticals announces that it has launched Entecavir Tablets. The drug is the generic version of Baraclude®, which is used to treat chronic Hepatitis B.
Entecavir is available from Camber in .5mg 30 and 90 count bottles and 1mg 30 count bottles.
If you would like more information about this topic, please contact Megan Becker at 732.529.0436 or email at [email protected].
Recent articles
- Camber Launches Nilotinib Capsules
- Camber Awarded 2025 Supplier of the Year by OptiSource
- Camber Launches Eletriptan Hydrobromide Tablets
- Camber Launches Abacavir and Lamivudine Tablets, USP
- Camber’s Parent Company, Hetero, Partners with the Gates Foundation to Supply Generic Lenacapavir for HIV Prevention
- Camber Adds 800 mg Darunavir Tablets to Product Family






